ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 76 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $451,000 | +2.3% | 210,000 | +50.0% | 0.17% | +5.0% |
| Q1 2017 | $441,000 | -29.3% | 140,000 | -41.7% | 0.16% | -29.1% |
| Q4 2016 | $624,000 | -19.8% | 240,000 | +20.0% | 0.23% | -22.0% |
| Q3 2016 | $778,000 | +122.9% | 200,000 | +53.8% | 0.29% | +117.2% |
| Q2 2016 | $349,000 | +642.6% | 130,000 | +738.7% | 0.13% | +605.3% |
| Q1 2016 | $47,000 | -46.0% | 15,500 | -3.1% | 0.02% | -38.7% |
| Q3 2014 | $87,000 | – | 16,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,528,120 | $38,210,000 | 1.53% |
| Cormorant Asset Management, LP | 850,000 | $2,593,000 | 0.41% |
| Palo Alto Investors LP | 1,656,644 | $5,053,000 | 0.24% |
| Granahan Investment Management | 1,745,604 | $5,324,000 | 0.16% |
| Spark Investment Management LLC | 318,500 | $980,000 | 0.13% |
| Opus Point Partners Management, LLC | 57,747 | $176,000 | 0.10% |
| SHEPHERD KAPLAN KROCHUK, LLC | 76,472 | $233,000 | 0.06% |
| Joel Isaacson & Co., LLC | 70,660 | $216,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $229,000 | 0.05% |
| Cornerstone Capital, Inc. | 59,200 | $181,000 | 0.04% |